Quintrio
Home

Stock overview

Organigram Global Inc. Common Shares

OGI

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Last trade $0.7134
Day change -$0.0106 (-1.46%)
Day range $0.71 – $0.739
Volume 717,620
Market cap $102M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for OGI.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for OGI.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
The Motley Fool

Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?

Tilray Brands has not made a bid for Aurora Cannabis despite being an acquisition-hungry company, as its strategic focus has shifted toward U.S. beverage acquisitions and craft brewing rather than expanding in the competitive Canadian cannabis market. The company recently announced consolidation efforts in Canada to focus on profitability, making a major acquisition of a Canadian producer like Aurora less attractive to its long-term strategy.

Zacks Investment Research

Omeros (OMER) Surpasses Q3 Earnings and Revenue Estimates

Omeros (OMER) reported quarterly earnings of $0.06 per share, beating consensus estimates by a loss of $0.05 and delivering a +220% earnings surprise. The company posted revenues of $35.93 million, surpassing estimates by 16.29%. Despite strong earnings performance, Omeros shares have underperformed the S&P 500 year-to-date, gaining 1.8% versus the market's 10.5% gain. The stock holds a Zacks Rank #2 (Buy) rating based on favorable estimate revisions.

The Motley Fool

The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf

Organigram agreed to acquire Aurora Cannabis at a 21% premium over Curaleaf's hostile takeover offer. However, the article argues that Curaleaf emerges as the real winner because the combined Organigram-Aurora entity will be more entrenched in the declining Canadian recreational cannabis market. Curaleaf, with stronger financials and U.S. operations, may eventually acquire the combined company at a lower valuation if the deal underperforms.

Benzinga

Organigram Bets Big On Europe With Sanity Group Takeover

Organigram Global announced a proposed acquisition of Sanity Group, a German cannabis company, for €113.4 million upfront plus up to €113.8 million in earnout consideration. The deal aims to establish Organigram as a global cannabis pure-play with significant European market presence. Funding will come from cash on hand, a new credit facility, and a €47.8 million investment from British American Tobacco. OGI shares rose 7.09% in premarket trading, though technical indicators show bearish short-to-medium term trends.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jul 7, 20231-for-4reverse split